Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi

被引:3
作者
Aimaier, Rehanguli [1 ]
Chung, Manhon [1 ]
Zhu, Hainan [1 ]
Yu, Qingxiong [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China
关键词
giant congenital melanocytic nevi; mitogen-activated protein kinases; NRAS; MELANOMA; RISK; MUTATIONS; MODEL;
D O I
10.1111/exd.14527
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The mechanism underlying giant congenital melanocytic nevus (GCMN) formation is not fully understood. According to recent research, NRAS gene mutation is the main driving factor in GCMN. Melanocytic precursor cells proliferate during the embryonic stage after acquiring NRAS mutations. However, why GCMN undergoes intense proliferation in the embryonic stage and then stops postnatally remains unknown. The current theory for this phenomenon is that the GCMN undergoes oncogene-induced senescence. However, there is not enough evidence to indicate that senescence induces growth arrest in GCMN. In this study, we hypothesized that the expression level of the NRAS gene changes dynamically during the development and differentiation of neural crest cells into melanocytes and that the NRAS expression level determines whether the cell proliferates or becomes quiescent.
引用
收藏
页码:582 / 585
页数:4
相关论文
共 21 条
[1]   Congenital melanocytic nevi: Where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis [J].
Alikhan, Ali ;
Ibrahimi, Omar A. ;
Eisen, Daniel B. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) :495.e1-495.e17
[2]   Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations [J].
Bauer, Juergen ;
Curtin, John A. ;
Pinkel, Dan ;
Bastian, Boris C. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (01) :179-182
[3]   NRAS Mutation Is the Sole Recurrent Somatic Mutation in Large Congenital Melanocytic Nevi [J].
Charbel, Christelle ;
Fontaine, Romain H. ;
Malouf, Gabriel G. ;
Picard, Arnaud ;
Kadlub, Natacha ;
El-Murr, Nizar ;
How-Kit, Alexandre ;
Su, Xiaoping ;
Coulomb-L'Hermine, Aurore ;
Tost, Jorg ;
Mourah, Samia ;
Aractingi, Selim ;
Guegan, Sarah .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (04) :1067-1074
[4]  
Joselow A, 2017, METHODS MOL BIOL, V1534, P175, DOI 10.1007/978-1-4939-6670-7_17
[5]   How to Choose the Right Inducible Gene Expression System for Mammalian Studies? [J].
Kallunki, Tuula ;
Barisic, Marin ;
Jaattela, Marja ;
Liu, Bin .
CELLS, 2019, 8 (08)
[6]   Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS [J].
Kinsler, Veronica A. ;
Thomas, Anna C. ;
Ishida, Miho ;
Bulstrode, Neil W. ;
Loughlin, Sam ;
Hing, Sandra ;
Chalker, Jane ;
McKenzie, Kathryn ;
Abu-Amero, Sayeda ;
Slater, Olga ;
Chanudet, Estelle ;
Palmer, Rodger ;
Morrogh, Deborah ;
Stanier, Philip ;
Healy, Eugene ;
Sebire, Neil J. ;
Moore, Gudrun E. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (09) :2229-2236
[7]   Melanoma risk in congenital melanocytic naevi:: a systematic review [J].
Krengel, S ;
Hauschild, A ;
Schäfer, T .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) :1-8
[8]   A model for RAS mutation patterns in cancers: finding the sweet spot [J].
Li, Siqi ;
Balmain, Allan ;
Counter, Christopher M. .
NATURE REVIEWS CANCER, 2018, 18 (12) :767-777
[9]   BRAFE600-associated senescence-like cell cycle arrest of human naevi [J].
Michaloglou, C ;
Vredeveld, LCW ;
Soengas, MS ;
Denoyelle, C ;
Kuilman, T ;
van der Horst, CMAM ;
Majoor, DM ;
Shay, JW ;
Mooi, WJ ;
Peeper, DS .
NATURE, 2005, 436 (7051) :720-724
[10]   A Mouse Model of Melanoma Driven by Oncogenic KRAS [J].
Milagre, Carla ;
Dhomen, Nathalie ;
Geyer, Felipe C. ;
Hayward, Robert ;
Lambros, Maryou ;
Reis-Filho, Jorge S. ;
Marais, Richard .
CANCER RESEARCH, 2010, 70 (13) :5549-5557